Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |